V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320002994 | 320001784 | 1.66 | 58.2 | Palliative (P) | 2015-05-06 | 2015-05-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320017615 | CISPLATIN + GEMCITABINE |
| 320002995 | 320001785 | 1.76 | 61.5 | Neo-adjuvant (N) | 2014-02-03 | 2014-02-03 | CETUXIMAB | 02 | N | 320017618 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320002996 | 320001785 | 1.6 | null | Neo-adjuvant (N) | 2016-08-16 | 2016-08-22 | Carboplatin + Etoposide IV 3 day | null | N | 320017618 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320002997 | 320001786 | null | 42.2 | Palliative (P) | 2013-11-15 | 2013-11-21 | Carboplatin + Pemetrexed | N | N | 320017635 | ICON TRIAL |
| 320002998 | 320001787 | null | 54.45 | Neo-adjuvant (N) | 2016-12-03 | 2016-12-03 | CAPECITABINE + OXALIPLATIN | null | null | 320017638 | CETUXIMAB + RT |
| 320002999 | 320001787 | 1.58 | 79.4 | Curative (C) | 2015-08-21 | 2015-08-29 | Docetaxel 75mg/m2 (21 day) | null | N | 320017638 | CETUXIMAB + RT |
| 320003000 | 320001788 | 1.72 | null | Curative (C) | 2015-10-22 | 2015-11-08 | PEMBROLIZUMAB | N | Y | 320017653 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003001 | 320001789 | 1.63 | 134 | Neo-adjuvant (N) | 2016-01-13 | 2016-01-28 | Bevacizumab 7.5mg/kg | N | N | 320017655 | CETUXIMAB |
| 320003002 | 320001790 | 1.72 | 84.3 | Adjuvant (A) | 2015-06-08 | 2015-06-13 | BCG Intravesical | 02 | N | 320017657 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003003 | 320004926 | 1.73 | 69.05 | Neo-adjuvant (N) | 2014-03-06 | 2014-03-10 | Cisplatin + Etoposide (3 day) | Y | N | 320017665 | EVEROLIMUS |
| 320003004 | 320004926 | null | 105.6 | Palliative (P) | 2017-07-06 | 2017-07-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 320017665 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003005 | 320001791 | 1.66 | 69 | Curative (C) | 2015-08-25 | 2015-10-01 | CNS Choriod Plexus SIOP 2009, CycEV | N | Y | 320017674 | POUT TRIAL |
| 320003006 | 320001792 | 1.82 | 49.6 | Disease modification (D) | 2017-02-01 | 2017-02-02 | EV + LOMUSTINE | N | N | 320017677 | TEMOZOLOMIDE |
| 320003007 | 320001793 | 1.57 | 60 | Palliative (P) | 2017-03-28 | 2017-03-28 | PACLITAXEL | 01 | N | 320017678 | BEVACIZUMAB |
| 320003008 | 320001794 | 1.76 | 105.6 | Palliative (P) | 2015-04-04 | 2015-04-04 | Carboplatin + Vinorelbine Oral | N | N | 320017683 | PACLITAXEL |
| 320003009 | 320001794 | null | 66 | Palliative (P) | 2016-07-24 | 2016-07-25 | GEMCITABINE | Y | N | 320017683 | PEMBROLIZUMAB |
| 320003010 | 320001795 | 1.61 | 46 | Curative (C) | 2014-11-27 | 2014-12-18 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | Y | 320017697 | PACLITAXEL |
| 320003011 | 320001796 | 1.6 | 82.2 | Neo-adjuvant (N) | 2015-07-19 | 2015-07-27 | CARBOPLATIN + RT | N | N | 320017701 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003012 | 320001797 | null | null | Neo-adjuvant (N) | 2015-08-18 | 2015-08-24 | PACLITAXEL | 02 | N | 320017705 | CARBOPLATIN + RT |
| 320003013 | 320001798 | 1.74 | 106.2 | Palliative (P) | 2015-08-06 | 2015-08-07 | BENDAMUSTINE + RITUXIMAB | N | N | 320017715 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 320003016 | 320001799 | 1.79 | 82.3 | Palliative (P) | 2016-12-07 | 2016-12-07 | Gemcitabine weekly | N | N | 320017733 | CAPECITABINE |
| 320003017 | 320001800 | null | 90 | Curative (C) | 2013-10-07 | 2013-10-22 | Trial Unspecified | N | N | 320017741 | CHOP R |
| 320003018 | 320001801 | 1.66 | 59 | Adjuvant (A) | 2017-04-08 | 2017-04-12 | Capecitabine (21days) + Carboplatin | 02 | N | 320017744 | BEVACIZUMAB |
| 320003019 | 320001802 | 1.58 | 60.3 | Palliative (P) | 2018-03-20 | 2018-03-21 | ECX | 01 | null | 320017745 | TRIAL |
| 320003020 | 320001803 | 1.6 | 73 | Palliative (P) | 2013-12-04 | 2013-12-05 | ICON8 TRIAL | N | N | 320017746 | CARBOPLATIN + DOCETAXEL |
| 320003021 | 320001803 | 1.77 | 78.5 | Curative (C) | 2017-03-19 | 2017-04-06 | Cisplatin + Vinorelbine (IV) | N | N | 320017746 | CISPLATIN + GEMCITABINE |
| 320003022 | 320001804 | 1.59 | 60 | null | 2017-02-21 | 2017-02-24 | CYCLOPHOSPHAMIDE + EPIRUBICIN + PACLITAXEL | N | null | 320017755 | NOT MATCHED |
| 320003023 | 320001805 | null | 52 | null | 2016-06-19 | 2016-06-23 | Cisplatin + Vinorelbine (IV) | N | N | 320017756 | CHOP R |
| 320003024 | 320001806 | 0 | 69 | Adjuvant (A) | 2017-08-03 | 2017-08-12 | Doxorubicin + Ifosfamide | N | N | 320017764 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 320003025 | 320001806 | 1.57 | 42 | Neo-adjuvant (N) | 2017-05-10 | 2017-05-16 | CARBOPLATIN + RT | N | N | 320017764 | TRASTUZUMAB |
| 320003026 | 320001806 | 1.67 | 65 | Curative (C) | 2016-04-30 | 2016-05-01 | Cetuximab + CISPLATIN + FLUOROURACIL | Y | N | 320017764 | CARBOPLATIN + ETOPOSIDE |
| 320003027 | 320001807 | 1.65 | 73.5 | Palliative (P) | null | 2015-10-13 | CETUXIMAB | null | null | 320017781 | ECX |
| 320003028 | 320001808 | null | 59.4 | Palliative (P) | 2018-03-13 | 2018-03-14 | STS Rhabdo VIT0910 Vinc Irino Temoz | null | null | 320017787 | CETUXIMAB + RT |
| 320003029 | 320001808 | null | null | Neo-adjuvant (N) | 2016-04-14 | 2016-04-23 | Cisplatin + Pemetrexed | N | N | 320017787 | CAPECITABINE + CISPLATIN |
| 320003030 | 320006307 | 1.8 | 73 | Palliative (P) | 2014-02-03 | 2014-02-14 | Trial Unspecified | N | N | 320017792 | CISPLATIN + GEMCITABINE |
| 320003031 | 320001809 | 1.7 | 64.4 | Palliative (P) | 2016-12-06 | 2016-09-20 | Bevacizumab+Carbo+Pacliaxel | null | N | 320017800 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320003032 | 320001810 | 1.64 | -1 | Palliative (P) | 2018-11-01 | 2018-11-18 | Bevacizumab+Carbo+Pacliaxel | N | N | 320017816 | FLUOROURACIL + MITOMYCIN + RT |
| 320003033 | 320001811 | 1.71 | null | Palliative (P) | 2016-03-25 | 2016-03-25 | PEMBROLIZUMAB | 02 | N | 320017823 | PMB |
| 320003034 | 320001812 | 1.67 | 88.6 | Neo-adjuvant (N) | 2014-11-02 | 2014-11-02 | CETUXIMAB + RT | 2 | N | 320017824 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003035 | 320001813 | 1.87 | 76.1 | Adjuvant (A) | null | 2015-11-12 | Cisplatin + Vinorelbine (IV) | N | Y | 320017828 | CETUXIMAB |
| 320003036 | 320001814 | 1.58 | 61 | null | 2015-12-04 | 2016-08-02 | Ipilimumab | 02 | N | 320017831 | PEMBROLIZUMAB |
| 320003037 | 320001815 | 1.63 | 71.2 | Palliative (P) | 2014-10-20 | 2014-10-21 | ECX | N | N | 320017835 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003038 | 320001816 | null | null | Adjuvant (A) | 2018-05-18 | 2018-05-31 | CETUXIMAB + RT | 2 | N | 320017838 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003039 | 320001817 | 1.55 | 121 | Palliative (P) | 2015-04-03 | 2015-04-03 | BENDAMUSTINE + RITUXIMAB | 02 | N | 320017853 | CAPECITABINE |
| 320003040 | 320001817 | 1.7 | 74.2 | Curative (C) | 2016-04-28 | 2016-06-04 | Bevacizumab 7.5mg/kg | N | N | 320017853 | IMATINIB |
| 320003041 | 320001818 | 1.62 | 77.1 | Palliative (P) | 2016-07-05 | 2016-07-10 | Carboplatin + Pemetrexed | N | N | 320017861 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320003042 | 320001818 | 0 | 69 | Palliative (P) | 2014-10-10 | 2014-12-23 | Folfirinox | N | N | 320017861 | CARBOPLATIN + RT |
| 320003043 | 320001818 | 1.87 | 91 | Palliative (P) | null | 2014-06-16 | PEMBROLIZUMAB | N | N | 320017861 | CETUXIMAB + RT |
| 320003044 | 320001819 | 1.65 | null | Palliative (P) | 2017-09-27 | 2017-10-04 | CISPLATIN + ETOPOSIDE | N | N | 320017869 | PACLITAXEL |
| 320003045 | 320001820 | 1.62 | 61.1 | null | 2017-02-28 | 2017-02-28 | CISPLATIN + GEMCITABINE | 02 | null | 320017876 | MPV |